TURNOVER (x1000 NOK)
NET PROFIT (x1000 NOK)
EMPLOYEES
Boston Scientific Nordic AB
Closing information (x1000 NOK)
| Closing information | 2024/12 | 2023/12 | 2022/12 |
| Turnover |
1,459,461
|
1,359,310
|
1,130,786 |
| Financial expenses |
158
|
829
|
428 |
| Earnings before taxes |
38,073
|
43,482
|
30,176 |
| EBITDA |
44,496
|
49,964
|
36,962 |
| Total assets |
519,276
|
449,375
|
398,143 |
| Current assets |
495,965
|
427,930
|
380,386 |
| Current liabilities |
265,132
|
231,280
|
221,257 |
| Equity capital |
254,144
|
218,095
|
176,886 |
| - share capital |
103
|
101
|
95 |
| Employees (average) |
136
|
126
|
120 |
Financial ratios
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Solvency |
48.9%
|
48.5%
|
44.4% |
| Turnover per employee |
10,731
|
10,788
|
9,423 |
| Profit as a percentage of turnover |
2.6%
|
3.2%
|
2.7% |
| Return on assets (ROA) |
7.4%
|
9.9%
|
7.7% |
| Current ratio |
187.1%
|
185.0%
|
171.9% |
| Return on equity (ROE) |
15.0%
|
19.9%
|
17.1% |
| Change turnover |
75,642
|
148,288
|
100,448 |
| Change turnover % |
5%
|
12%
|
10% |
| Chg. No. of employees |
10
|
6
|
7 |
| Chg. No. of employees % |
8%
|
5%
|
6% |
Total value of public sale
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.